ZeroStack Corp.
ZeroStack Corp.
- Market cap
- $56.24M
Your view on ZSTK
Overview
What the company does, where it operates, and who runs it.
About ZeroStack Corp.
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Daniel Reis-Faria
- Headquarters
- 40 King Street West, Toronto, ON, CA
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Daniel Reis-Faria
- Headquarters
- 40 King Street West, Toronto, ON, CA
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments.
The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants.
It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies.
The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for ZeroStack Corp.. Starting points for ZeroStack Corp.: EPS -$17.85, beta 1.71 — an Asset Management name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for ZeroStack Corp.. Trailing twelve-month EPS for ZeroStack Corp. stands at -$17.85. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Targets, low to high
Analyst ratings
6 ratings- Strong Buy0
- Buy4
- Hold2
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterSep 2026 | Next quarterDec 2026 | This yearYear to Dec 2026 |
|---|---|---|---|
| Average estimate | −$0.12 | −$0.12 | −$4.02 |
| Lowest estimate | −$0.12 | −$0.12 | −$4.02 |
| Highest estimate | −$0.12 | −$0.12 | −$4.02 |
| Number of analysts | 1 | 1 | 1 |
| A year ago | −$4.931 | −$35.321 | −$43.491 |
| Growth vs a year ago | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2026 | Next quarterDec 2026 | This yearYear to Dec 2026 |
|---|---|---|---|
| Average estimate | $7.40M | $7.50M | $29.50M |
| Lowest estimate | $7.40M | $7.50M | $29.50M |
| Highest estimate | $7.40M | $7.50M | $29.50M |
| Number of analysts | 1 | 1 | 1 |
| A year ago | $9.75M | $9.35M | $35.68M |
| Growth vs a year ago | −24.1% | −19.8% | −17.3% |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for ZeroStack Corp.. ZeroStack Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| AIMAIM ImmunoTech Inc. | Healthcare | Biotechnology | $4.6M | ||
| AKANAkanda Corp. | Healthcare | Drug Manufacturers - Specialty & Generic | $10.1M | ||
| AMIXAutonomix Medical, Inc. Common Stock | Healthcare | Medical - Devices | $484,136 | ||
| CPHIChina Pharma Holdings, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $18.9M | ||
| ENSCEnsysce Biosciences, Inc. | Healthcare | Biotechnology | $7.0M | ||
| KALAKALA BIO, Inc. | Healthcare | Biotechnology | $1.7M | ||
| KZIAKazia Therapeutics Limited | Healthcare | Biotechnology | $8.0M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| TRRPFTorrent Capital Ltd. | Financial Services | OTC | $14.9M | ||
| TSLXSixth Street Specialty Lending, Inc. | Financial Services | NYSE | $1.6B | ||
| TSRUFPacific Current Group Limited | Financial Services | OTC | $200.7M | ||
| TUXSTuxis Corporation | Financial Services | OTC | $2.8M | ||
| TVL.AXTouch Ventures Limited | Financial Services | ASX | — | ||
| TWAVTaoWeave, Inc. | Financial Services | NASDAQ | $4.5M | ||
| TY-PTri-Continental Corporation PFD $2.50 | Financial Services | NYSE | $1.8B | ||
| UBAAFUrbana Corporation | Financial Services | OTC | $262.5M | ||
| URB-A.CNUrbana Corporation | Financial Services | CNQ | $424.7M | ||
| URB-A.TOUrbana Corporation | Financial Services | TSX | $366.4M | ||
| URB.CNUrbana Corporation | Financial Services | CNQ | $503.4M | ||
| URB.TOUrbana Corporation | Financial Services | TSX | $359.1M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VXFVanguard Extended Market ETF | $30.2B in assets | 0.00% | |
| VTIVanguard Total Stock Market ETF | $689.2B in assets | — | |
| VUN.TOVanguard U.S. Total Market Index ETF | $20.1B in assets | — | |
| VEQT.TOVanguard All-Equity ETF Portfolio | $17.6B in assets | — | |
| VGRO.TOVanguard Growth ETF Portfolio | $10.9B in assets | — | |
| VBAL.TOVanguard Balanced ETF Portfolio | $6.0B in assets | — | |
| VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged) | $1.4B in assets | — | |
| VCNS.TOVanguard Conservative ETF Portfolio | $977M in assets | — | |
Largest holders first, then the funds most concentrated in ZSTK.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold ZeroStack Corp., and how their positions are changing. At a $56.2M market value, institutional positions materially move ZeroStack Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by ZeroStack Corp. executives and directors. Shares of ZeroStack Corp. have traded between $1.32 and $15.04 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for ZeroStack Corp.. Coverage tracks ZeroStack Corp. within Asset Management (Financial Services). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of ZeroStack Corp.